Axonics Modulation Technologies Inc at UBS Global Healthcare Conference Transcript
Thanks, everybody, for joining us for this session. I'm here with management from Axonics, and wanted to give them a brief intro here before we get into our presentation.
We have Ray Cohen, the CEO of Axonics here. He's going to take us through the value proposition that the company's kind of on the cusp of bringing to market here. And Mr. Cohen is a public company director with over 35 years of experience in leading medical device companies and serving as a Board member for a number of private and publicly traded life science companies. You may know him -- from 2010 to '12, he served as CEO of venture capital backed Vessix Vascular, which was acquired by Boston Sci in November of 2012.
So I think there's probably too much more background to go into here, but Ray, let me turn it over to you to go through the presentation, and we'll do some questions if we have time. Thanks.
Thanks, Matt. So good morning, everybody, and thank you for coming to this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |